Jack Meehan
Stock Analyst at Barclays
(3.08)
# 1,336
Out of 4,761 analysts
133
Total ratings
69.51%
Success rate
21.26%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $271 → $260 | $249.85 | +4.06% | 13 | Feb 7, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $135.37 | -7.66% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $374.82 | -23.16% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $17.30 | +90.75% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $94.20 | +245.01% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $18.90 | +0.53% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $172.24 | -42.52% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $201.39 | -10.62% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $14.18 | -29.48% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $191.04 | -13.11% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $64.49 | -33.32% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $163.02 | -5.53% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $312.05 | +37.80% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $280.08 | +53.53% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $40.46 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $50.82 | -5.55% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,286.54 | -47.15% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $111.71 | -73.14% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $532.55 | -43.67% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.64 | +2,339.02% | 1 | Dec 11, 2017 |
Labcorp Holdings
Feb 7, 2025
Maintains: Equal-Weight
Price Target: $271 → $260
Current: $249.85
Upside: +4.06%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $135.37
Upside: -7.66%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $374.82
Upside: -23.16%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $17.30
Upside: +90.75%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $94.20
Upside: +245.01%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $18.90
Upside: +0.53%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $172.24
Upside: -42.52%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $201.39
Upside: -10.62%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $14.18
Upside: -29.48%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $191.04
Upside: -13.11%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $64.49
Upside: -33.32%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $163.02
Upside: -5.53%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $312.05
Upside: +37.80%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $280.08
Upside: +53.53%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $40.46
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $50.82
Upside: -5.55%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,286.54
Upside: -47.15%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $111.71
Upside: -73.14%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $532.55
Upside: -43.67%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.64
Upside: +2,339.02%